1. Home

Media Centre

PHASE Scientific Launches World's Largest Urine-Based Cervical Cancer (HPV) Screening Clinical Study

PHASE Scientific Launches World's Largest Urine-Based Cervical Cancer (HPV) Screening Clinical Study

Press Release

September 22, 2025

PHASE Scientific Honored in Forbes Asia 100 To Watch 2025

PHASE Scientific Honored in Forbes Asia 100 To Watch 2025

News

August 26, 2025

PHASE Scientific Expands INDICAID® Respiratory Portfolio with Exclusive U.S. Launch of Novel FebriDx® Test

PHASE Scientific Expands INDICAID® Respiratory Portfolio with Exclusive U.S. Launch of Novel FebriDx® Test

Press Release

July 14, 2025

PHASE Scientific Shines at HKIC International Forum for Patient Capital

PHASE Scientific Shines at HKIC International Forum for Patient Capital

Press Release

May 22, 2025

PHASE Scientific Raises US$34 Million Series A Round to Advance Urine-Based Diagnostic Technology for Early Disease Detection

PHASE Scientific Raises US$34 Million Series A Round to Advance Urine-Based Diagnostic Technology for Early Disease Detection

Press Release

May 20, 2025

Former Abbott China R&D Head Joins PHASE Scientific as Chief Scientific Officer to Drive Scientific Innovation and Global R&D Strategy

Former Abbott China R&D Head Joins PHASE Scientific as Chief Scientific Officer to Drive Scientific Innovation and Global R&D Strategy

Press Release

May 13, 2025

PHASE Scientific Earns Prestigious Recognition at 2025 ASCCP Scientific Meeting for Innovation in Urine-Based HPV Screening

PHASE Scientific Earns Prestigious Recognition at 2025 ASCCP Scientific Meeting for Innovation in Urine-Based HPV Screening

Press Release

April 29, 2025

Revolutionizing Cervical Cancer Screening: PHASiFY Technology Takes Spotlight at China National Conference

Revolutionizing Cervical Cancer Screening: PHASiFY Technology Takes Spotlight at China National Conference

Press Release

March 4, 2025

Illumina signs MoU with PHASE to Advance Oncology Testing in the Greater Bay Area and Contribute to a ''Healthy China'' and ''Healthy Hong Kong''

Illumina signs MoU with PHASE to Advance Oncology Testing in the Greater Bay Area and Contribute to a ''Healthy China'' and ''Healthy Hong Kong''

Press Release

November 7, 2024

All
Chiu's Blog
News
Opinion
Press Release
Video
Tender
Hong Kong Gives Biotech a Chance

Hong Kong Gives Biotech a Chance

News

June 1, 2019